Publication: Synthesis and investigation of anti-inflammatory and anticonvulsant activities of novel coumarin-diacylated hydrazide derivatives
dc.contributor.author | ÇAM, MUHAMMET EMİN | |
dc.contributor.authors | Tapanyigit, Ozan; Demirkol, Onur; Guler, Ece; Ersatir, Mehmet; Cam, Muhammet Emin; Giray, Elife Sultan | |
dc.date.accessioned | 2022-03-14T09:20:20Z | |
dc.date.available | 2022-03-14T09:20:20Z | |
dc.date.issued | 2020-12 | |
dc.description.abstract | A number of novel coumarin derivatives synthesized by the reaction of 3-carbonyl chloride coumarin with some substituted aryl acid hydrazides to investigate their anti-inflammatory and anticonvulsant activities. Carrageenan (0.1 ml of 1%, w/v) was injected subplantarly in the right paw of rats to induce an acute model of inflammation. Anti-inflammatory efficacy was evaluated for 5 hours at 3 different dosages 5, 10, 25 mg/kg. After that, the changes in the level of paw edema volumes and percentage inhibition of all groups were observed and the most effective coumarin derivative was found as N'-(2-hyroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide. In addition, N'-(2-oxo-2H-chromene-3-carbonyl)nicotinohydrazide, (E)-N'-(3-(4-hydroxyphenyl)acryloyl)-2-oxo-2H-chromene-3-carbohydrazide, and N'-(5-amino-2-hydroxybenzoyl)-2-oxo-2H-chromone-3carbohydrazide showed their anti-inflammatory effects in a dose-dependent manner. On the other hand, pentylenetetrazole (PTZ, 80 mg/kg, i.p.)-induced seizure model was used to investigate the anticonvulsant activities of six newly synthesized coumarin derivatives in mice. Hybrid compound of salicylic acid hydrazide and 3-carbonyl chloride coumarin (8d) was found the most promising anticonvulsant agent among all treatment groups according to the onset of seizure and survival rate. Moreover, (E)-N'-cinnamoyl-2-oxo-2H-chromene-3-carbohyrazide (8b) and (E)-N'-(3-(4-hyroxy phenyl)acryloyl)-2-oxo-2H-chromene-3-carbohydrazide (8c) has potential anticonvulsant efficiency in low doses (30 mg/kg). The anticonvulsant effect of these coumarin derivatives may be through enhanced GABA-mediated inhibition in the brain. (C) 2020 Published by Elsevier B.V. on behalf of King Saud University. | |
dc.identifier.doi | 10.1016/j.arabjc.2020.10.034 | |
dc.identifier.eissn | 1878-5379 | |
dc.identifier.issn | 1878-5352 | |
dc.identifier.uri | https://hdl.handle.net/11424/242985 | |
dc.identifier.wos | WOS:000600552400045 | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER | |
dc.relation.ispartof | ARABIAN JOURNAL OF CHEMISTRY | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Anti-inflammatory activity | |
dc.subject | Anticonvulsant activity | |
dc.subject | Coumarin-diacylated hydrazide | |
dc.subject | Pentylenetetrazole-induced seizures | |
dc.subject | Carrageenan-induced paw edema | |
dc.subject | N,N'-DIACYLHYDRAZINE DERIVATIVES | |
dc.subject | BIOLOGICAL-ACTIVITIES | |
dc.subject | ACID-DERIVATIVES | |
dc.subject | SEIZURE ACTIVITY | |
dc.subject | ANTIOXIDANT | |
dc.subject | EPILEPSY | |
dc.subject | EXTRACT | |
dc.subject | METHYL | |
dc.subject | BIOACTIVITY | |
dc.title | Synthesis and investigation of anti-inflammatory and anticonvulsant activities of novel coumarin-diacylated hydrazide derivatives | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | a01eb685-dd81-4861-a7c0-24af7f6f4b5d | |
local.import.package | SS16 | |
local.indexed.at | WOS | |
local.indexed.at | SCOPUS | |
local.journal.numberofpages | 13 | |
local.journal.quartile | Q2 | |
oaire.citation.endPage | 9117 | |
oaire.citation.issue | 12 | |
oaire.citation.startPage | 9105 | |
oaire.citation.title | ARABIAN JOURNAL OF CHEMISTRY | |
oaire.citation.volume | 13 | |
relation.isAuthorOfPublication | 96f1bd4e-81dc-4c34-bbf2-e15edc6f01b3 | |
relation.isAuthorOfPublication.latestForDiscovery | 96f1bd4e-81dc-4c34-bbf2-e15edc6f01b3 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Synthesis and investigation of anti-inflammatory.pdf
- Size:
- 2.1 MB
- Format:
- Adobe Portable Document Format